Question 1

What is LOPJLB’s current signal on BRNS?

Accepted Answer

LOPJLB’s latest quantitative signal on Barinthus Biotherapeutics plc (BRNS) is BUY in a RECOVERY regime. Signals are updated daily.

Question 2

What market regime is BRNS in?

Accepted Answer

Barinthus Biotherapeutics plc (BRNS) is currently classified in the RECOVERY HMM market regime on LOPJLB.

Question 3

What does Barinthus Biotherapeutics plc (BRNS) do?

Accepted Answer

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 …

Question 4

Where is Barinthus Biotherapeutics plc based / listed?

Accepted Answer

Barinthus Biotherapeutics plc is based in US, listed on NASDAQ.

Barinthus Biotherapeutics plc (BRNS)

Key stats

Prediction markets

Company news